Portfolio of Marijuana (Cannabis) Pharma Stocks Traded on U.S. Exchanges

Here is a table of 14 cannabis stocks that are developing cannabis compound medicines.

To inspect the performance of the Cannabis Pharma Stocks portfolio, see the chart of portfolio below. Portfolio values are computed using monthly closes for stocks from Quandl.

The 7 stocks included in the portfolio computations are: ABBV, ARNA, CARA, CRBP, GWPH, INSY and ZYNE. The current value of the portfolio assumes that $1,428.57 was invested (total of $10,000) in each stock at its closing monthly price for the current date in 2016. All prices are adjusted for splits and dividends. The 7 stocks excluded from the portfolio computations because of insufficient price data are: AXIM, CNBX, GBLX, OWCP, PMCB, CNAB and VBIO.

The current value of a $10,000 investment is $14,968. The percent return is 49.68%. The annualized return is 12.21%.


NOTE: The stocks included in the table and chart are representative of the industry. They are not recommendations.

Related Portfolios

Database with Comments of Marijuana (Cannabis) Stocks (A-Z)

Portfolio of Marijuana (Cannabis) Growers Stocks Traded on U.S. Exchanges

Portfolio of Marijuana (Cannabis) Stocks

Portfolio of Marijuana (Cannabis) Stocks Traded on OTC Markets